1998
DOI: 10.1016/s0166-6851(97)00247-8
|View full text |Cite
|
Sign up to set email alerts
|

Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
92
2

Year Published

2002
2002
2013
2013

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(100 citation statements)
references
References 33 publications
6
92
2
Order By: Relevance
“…17,28,36 Size polymorphism in this region is resulted from variation in number of copies of the 18-basepair repeat, which is not essential for substrate binding. 21 Most (77.0%) of the isolates sequenced contain three copies of the repeat, and 23.0% contained two 18-basepair repeats.…”
Section: Resultsmentioning
confidence: 99%
“…17,28,36 Size polymorphism in this region is resulted from variation in number of copies of the 18-basepair repeat, which is not essential for substrate binding. 21 Most (77.0%) of the isolates sequenced contain three copies of the repeat, and 23.0% contained two 18-basepair repeats.…”
Section: Resultsmentioning
confidence: 99%
“…32 including French Guyana, Surinam, Burma, Cambodia, Indonesia, Madagascar, and Comoros Islands); and Pvs25 (10 isolates from Colombia, Honduras, Venezuela, Nicaragua, Brazil, Indonesia, North Korea, Mauritania, and Papua New Guinea). The sampling covers the distribution of P. vivax including alleles from New World and Old World isolates (22).…”
Section: Methodsmentioning
confidence: 99%
“…Although chloroquine (CQ) still constitutes the first-line therapy against vivax malaria, CQ resistance has been reported in both Asia and South America (Rieckman, 1989;Baird et al, 1991;Malar-Than et al, 1995;Phillips et al, 1996). In addition, resistance to the antifolate drug pyrimethamine is also widespread (de Pecoulas et al, 1998;Imwong et al, 2003). Therefore, global resurgence of vivax malaria and escalating drug-resistance demand more extensive research and control efforts.…”
Section: Introductionmentioning
confidence: 99%